Drawing for CAREMIN

USPTO serial 79250037

CAREMIN

Reviewed by CopyMark Law Group

Reg. 5816210Status 709
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
SMITH, CYNTHIA RINALDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CAREMIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Electronic light therapy apparatus for treatment of skin and mucous membranes damaged by radio therapy or chemotherapy, treatment of skin wounds and dermatological care; electronical light therapy apparatus using fiber-optic fabrics for treatment of skin and mucous membranes damaged by radio therapy and chemotherapy, treatment of skin wounds and dermatological care; Electronic light phototherapy apparatus for medical use for the skin; Electronic light therapy apparatus for the skin using fiber optic fabrics for medical use; Electronic light therapy for apparatus for the skin for medical use; Electronic red light and near infrared light therapy apparatus for the skin for medical use; heat lamps for medical use; Ultraviolet ray lamps for medical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 13, 2026C71TCANCELLED SECTION 71—
Nov 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 13, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 25, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 25, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NPUBNOTICE OF PUBLICATION—
Apr 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 8, 2019ALIEASSIGNED TO LIE—
Apr 5, 2019RFNTREFUSAL PROCESSED BY IB—
Apr 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 18, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 8, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 7, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 25, 2019DOCKASSIGNED TO EXAMINER—
Jan 29, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 24, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance